查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2018704

捐卵子体外受精服务市场：2026年至2032年全球市场预测（依来源类型、捐赠者类型、支付模式、受赠者年龄层和诊所类型划分）

Donor Egg IVF Services Market by Source Type, Donor Type, Payment Model, Recipient Age Group, Clinic Type - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，捐卵子体外受精服务市场价值将达到 27.4 亿美元，到 2026 年将成长至 30.1 亿美元，到 2032 年将达到 54.6 亿美元，复合年增长率为 10.31%。

主要市场统计数据
基准年 2025 27.4亿美元
预计年份：2026年 30.1亿美元
预测年份：2032年 54.6亿美元
复合年增长率 (%) 10.31%

简要介绍动态的供卵子体外受精生态系统，向领导者介绍策略决策中使用的临床、商业性和营运重点。

体外受精捐卵子领域正经历快速变革，其驱动力来自临床实践、患者群体和服务模式的同步演变。本执行摘要旨在为医疗保健高管、诊所营运者、保险公司和投资者等相关人员提供关键洞察，帮助他们快速了解临床方案、病人历程和营运框架等方面的最新趋势。

快速的临床创新、数位化病人历程以及不断变化的监管预期，是如何重新定义体外受精服务和利用卵子捐赠的医疗服务提供者策略的？

体外受精捐卵子领域正经历着一场变革，这得益于技术创新、监管改革以及患者期望的不断变化，所有这些因素都在推动服务设计和交付方式的转型。冷冻保存技术和检查室流程的进步降低了结果的变异性，提高了可预测性，从而促进了冷冻捐卵子的使用，并催生了新的物流模式，在不影响临床品质的前提下，扩大了服务范围。

评估近期美国关税措施如何重塑了关于卵子捐赠实践、供应链韧性以及体外受精服务中患者成本负担的考虑。

美国近期的贸易和关税趋势正对捐卵子体外受精服务的营运经济效益和供应链稳定性产生直接和间接的累积影响。影响进口实验室设备、冷冻保存耗材和专用医疗设备的关税措施，使依赖全球供应商的诊所的采购流程变得更加复杂，促使许多诊所重新评估其供应商多元化、库存策略和长期资本规划。

深入了解来源类型、捐赠者关係、支付模式、接受者年龄组和诊所形式如何影响临床管道和服务经济。

要理解市场的内部结构，最好采用层级细分法，这种方法会影响临床通路、定价和病患体验。卵子来源类型仍然是一个主要区别因素；传统上，活卵子与供卵者和受卵者之间即时进行週期调整相关，而冷冻卵子则提供了柔软性的排卵时间和更广泛的地域覆盖。在每个卵子来源类别中，选择何种手术方式，例如体外受精（IVF）联合或不联合卵胞浆内单一精子注射（ICSI），会影响检查室工作流程、资源分配和咨询需求，进而影响治疗时间安排和临床调整需求。

实际的区域洞察揭示了美洲、欧洲、中东和非洲以及亚太地区的市场动态如何推动病患流量、诊所策略和监管应对措施。

区域趋势正对美洲、欧洲、中东和非洲以及亚太地区的临床实践模式、病患流动和法律规范产生重大影响。在美洲，来自国内外患者的强劲需求，加上私立诊所格局的多样性以及与保险公司之间不断发展的对话，正促使医疗服务提供者优先考虑治疗结果的透明度、患者资金筹措方案以及能够适应跨境物流的综合护理路径。

公司层面的策略分析表明，临床品质、整合服务和伙伴关係生态系统如何为使用捐卵子的体外受精服务创造可持续的竞争优势。

在捐卵子体外受精（IVF）领域，主要企业正透过结合卓越的临床技术、垂直整合和以患者为中心的服务设计来脱颖而出。那些投资于专有捐卵者资料库、完善的筛检流程以及注重认证的品管系统的企业，往往能够赢得更强大的病患信任，并获得更多的出版伙伴关係。与基因检测实验室、冷冻保存供应商和物流服务商建立策略合作伙伴关係，使这些机构能够提供端到端的解决方案，从而减少流程摩擦和治疗结果的差异。

为诊所营运者和医疗保健系统领导者提供切实可行的优先建议，以增强临床韧性、与保险公司合作以及以患者为中心的服务提供。

为了在临床和经济逆境中蓬勃发展，产业领导者必须采取果断且优先的行动，在提升临床品质和病患信心的同时，增强营运弹性。首先，要实现供应链多元化，并建立关键设备和耗材的国内维护和库存管理能力，以降低贸易中断和关税延误的风险。同时，要投资于冷冻保存能力和检验的方案，从而实现灵活的排班，并扩大诊所的地理采购范围。

采用高度透明的混合方法研究途径，结合相关人员访谈、临床调查和监管趋势分析，得出可操作且检验的产业见解。

本分析整合了混合方法研究设计中的洞见，该设计结合了与关键相关人员的对话以及对第二手资料的全面回顾。主要研究包括对临床负责人、检查室经理、采购负责人和患者权益倡导团体代表的结构化访谈，揭示了营运挑战、与保险公司的互动以及患者体验的趋势。这些质性研究结果辅以有针对性的问卷调查，以了解诊所层级在捐赠者招募、冷冻保存方案和远端医疗整合方面的实践。

结论是，该整合突显了捐卵子体外受精服务中维持临床卓越性和营运灵活性所必需的策略重点、风险领域和平衡方法。

总之，目前捐卵子体外受精的现况呈现出机会与风险交织的复杂局面，需要临床医师、保险公司和相关人员采取谨慎的策略应对措施。技术进步和冷冻保存技术的改进正在拓展临床选择，并催生更灵活的服务模式，而数位化诊疗路径则有助于改善患者就诊途径和就医体验。同时，不断变化的贸易政策、保险公司应对措施的不一致以及日益严格的伦理监管也带来了营运和声誉方面的风险，这些风险必须得到积极应对。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：捐卵子体外受精服务市场：依来源类型划分

  • 新鲜捐卵子
  • 冷冻捐卵子

第九章：捐卵子体外受精服务市场：依捐卵类型划分

  • 匿名的
  • 已知捐赠者
    • 朋友
    • 兄弟姊妹

第十章：捐卵子体外受精服务市场：依支付模式划分

  • 保险范围
    • 全额赔偿
    • 部分补偿
  • 自费

第十一章：捐卵子体外受精服务市场：依受者年龄组别划分

  • 35-45岁
  • 45岁或以上
  • 35岁以下

第十二章：捐卵子体外受精服务市场：依诊所类型划分

  • 综合医院
  • 不孕症治疗专科诊所
    • 链
    • 独立的

第十三章：捐卵子体外受精服务市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：捐卵子体外受精服务市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：捐卵子体外受精服务市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国捐卵子体外受精服务市场

第十七章：中国捐卵子体外受精服务市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Akruti IVF Centre LLP
  • Apollo Fertility
  • Birla Fertility and IVF Center
  • CCRM North America, Inc.
  • Cloudnine Fertility
  • Cryos International A/S
  • Donor Egg Bank USA LLC
  • Fairfax Reproductive Services, LLC
  • Gaudium IVF Pvt. Ltd.
  • Genea Pty Ltd
  • Human Potential, Inc.
  • Indira IVF Hospital Pvt. Ltd.
  • Milann Fertility Centre
  • Morpheus Life Sciences Pvt. Ltd.
  • Nova IVF Fertility Pvt. Ltd.
  • Ovogene Ltd.
  • Prelude Fertility, Inc.
  • Raffles Medical Group Ltd.
  • SGF Fertility Services, LLC
  • Sims IVF Fertility Clinic Ltd.
  • The Boston IVF Collaborative, LLC
  • The Cape Fertility Clinic（Pty）Ltd.
  • Virtus Health Ltd.
  • Virtus Reproductive Partners, LLC
  • World Fertility Services Ltd.
Product Code: MRR-AD36CD898227

The Donor Egg IVF Services Market was valued at USD 2.74 billion in 2025 and is projected to grow to USD 3.01 billion in 2026, with a CAGR of 10.31%, reaching USD 5.46 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.74 billion
Estimated Year [2026] USD 3.01 billion
Forecast Year [2032] USD 5.46 billion
CAGR (%) 10.31%

Concise introduction framing the dynamic donor egg IVF ecosystem to orient leaders to clinical, commercial, and operational priorities for strategic decision-making

The donor egg IVF landscape is undergoing rapid transformation as clinical practice, patient demographics, and service delivery models evolve in parallel. This executive summary synthesizes the most critical insights for healthcare executives, clinic operators, payers, and investor stakeholders who require a concise, actionable synthesis of emerging dynamics across clinical protocols, patient journeys, and operational frameworks.

In crafting these insights, emphasis has been placed on clinical differentiation, patient access pathways, and the strategic responses of providers to regulatory and economic headwinds. The narrative that follows prioritizes clarity for decision-makers by translating complex clinical and commercial variables into strategic implications that can inform planning, partnerships, and investment. By focusing on the practical consequences of recent shifts in supply, demand, and policy, the analysis equips readers to make informed choices about service design, network expansion, and payer engagement.

Throughout the summary, attention is given to the drivers of change-technological advancement, evolving payer landscapes, demographic pressures, and cross-border patient flows-while also outlining actionable priorities for organizations intent on maintaining clinical excellence and commercial resilience. The approach balances clinical rigor with business pragmatism, offering insights that are immediately relevant to operational and strategic agendas.

How rapid clinical innovations, digital patient journeys, and evolving regulatory expectations are redefining donor egg IVF services and provider strategies

The donor egg IVF sector is being reshaped by a confluence of technological innovation, regulatory recalibration, and shifting patient expectations that together constitute transformative shifts in service design and delivery. Advances in cryopreservation techniques and laboratory protocols have reduced variability and improved predictability in outcomes, encouraging broader uptake of frozen donor eggs and enabling new logistics models that extend geographic reach without sacrificing clinical quality.

Concurrently, digital health platforms and telemedicine have streamlined initial patient engagement, psychosocial counseling, and coordination between sourcing clinics and treatment centers, thereby compressing timelines and lowering some barriers to access. Payer dialogues are maturing in parallel, with self-funded pathways remaining prominent while pockets of insurance coverage expand in jurisdictions where advocacy and policy alignment have progressed. These shifts are also prompting clinics to rethink bundled pricing and patient support services to improve transparency and continuity of care.

Ethical considerations and donor management protocols have become central to reputational risk and regulatory compliance. Amplified scrutiny around donor screening, informed consent, and long-term data governance is driving providers to adopt more rigorous accreditation and traceability frameworks. Finally, cross-border reproductive care patterns are evolving as patients weigh clinical quality, regulatory clarity, and cost, prompting clinics to develop integrated care pathways that include remote assessments, local follow-up arrangements, and coordinated logistics for embryo and sample transport.

Assessment of how recent United States tariff measures have reshaped procurement practices, supply chain resilience, and patient affordability considerations for IVF services

Recent trade and tariff developments in the United States have exerted a cumulative influence on the operational economics and supply chain stability of donor egg IVF services, with effects that are both direct and second-order. Tariff measures affecting imported laboratory equipment, cryopreservation consumables, and specialized medical devices have increased procurement complexity for clinics that rely on global vendors, prompting many to reassess vendor diversification, inventory strategies, and long-term capital planning.

These cost pressures have been met with strategic adjustments in procurement and clinical operations. Some providers have accelerated local sourcing where feasible, adopted longer inventory lead times, and invested in domestic maintenance capabilities to reduce reliance on cross-border shipment of critical parts. The tariff environment has also encouraged collaboration between clinics and manufacturers to explore alternative product specifications and compatible supply options that mitigate tariff exposure while preserving clinical standards.

On the demand side, tariff-induced cost inflation can indirectly affect patient affordability and the calculus of cross-border care. Patients evaluating treatment destinations are increasingly attentive to total cost of care, inclusive of logistics and potential customs-related delays. As a result, clinics that can demonstrate supply chain resilience, transparent pricing, and expedited logistics are positioned to sustain patient inflows. At the policy and payer levels, stakeholders are reassessing reimbursement contracts and cost-sharing frameworks to reflect changes in clinic operating cost structures influenced by trade policy dynamics.

Deep segmentation-driven insight that explains how source type, donor relationships, payer models, recipient age cohorts, and clinic formats shape clinical pathways and service economics

The market's internal architecture is best understood through layered segmentation that impacts clinical pathways, pricing, and patient experience. Source type remains a primary differentiator, with fresh donor eggs traditionally linked to immediate cycle coordination between donor and recipient and frozen donor eggs offering scheduling flexibility and broader geographic sourcing. Within each source category, procedural choices such as IVF with intracytoplasmic sperm injection and IVF without ICSI influence laboratory workflows, resource allocation, and counseling requirements, thereby affecting treatment timelines and clinical coordination needs.

Donor type introduces an alternate set of considerations. Anonymous donors underpin scalable recruitment programs and standardized screening workflows, while known donors-often friends or siblings-create unique legal, psychosocial, and clinical counseling needs that require tailored consent processes and family-centered support services. Payment model segmentation is equally consequential: insurance-covered pathways, whether full coverage or partial coverage, change the timing and complexity of approvals and prior authorization workflows, whereas self-funded patients typically navigate decisions differently, with a stronger focus on price transparency, financing options, and concierge-level support.

Recipient age group shapes clinical strategy and counseling priorities; patients under 35 may present different prognostic conversations than those in the 35 to 40, 41 to 45, or over 45 cohorts, influencing embryo transfer planning and adjunct therapies. Clinic type further differentiates market positioning and capability sets. General hospitals often bring integrated medical services and multidisciplinary care but may have less specialized donor recruitment capabilities, while specialized fertility clinics-whether part of a chain or independent-tend to emphasize brand-specific protocols, donor databases, and tailored patient navigation programs. Understanding how these segments intersect clarifies where operational investments will yield the greatest clinical and commercial returns.

Actionable regional intelligence revealing how Americas, Europe Middle East & Africa, and Asia-Pacific market dynamics drive patient flows, clinic strategies, and regulatory responses

Regional dynamics exert a profound influence on clinical practice patterns, patient mobility, and regulatory frameworks across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a heterogeneous landscape of private clinics and evolving payer conversations is coupled with strong demand from domestic patients and international visitors, leading providers to emphasize outcome transparency, patient financing solutions, and integrated care pathways that accommodate cross-border logistics.

Across Europe, the Middle East & Africa, variance in regulatory regimes and cultural perspectives drives distinct demand pockets and referral flows. Clinics in jurisdictions with clear donor anonymity rules or supportive reimbursement frameworks often attract patients seeking predictable regulatory environments, while regions with stricter consent or data rules necessitate enhanced compliance capabilities and patient education programs. In the Asia-Pacific, demographic pressures and rising middle-class demand are encouraging rapid expansion of specialized fertility services, investment in cryopreservation infrastructure, and emergence of regional centers that combine clinical excellence with competitive pricing to serve both domestic and international patients.

These regional profiles are not static; they interact through cross-border patient flows, supplier networks, and regulatory harmonization efforts. Providers that align their operational models to regional strengths-whether through targeted marketing, partnerships with referral networks, or localized compliance frameworks-can better manage patient expectations and operational risks while capitalizing on each region's distinct demand drivers.

Strategic company-level analysis showing how clinical quality, integrated services, and partnership ecosystems are creating durable competitive advantages in donor egg IVF services

Leading organizations in the donor egg IVF arena are differentiating through a combination of clinical excellence, vertical integration, and patient-centric service design. Companies that have invested in proprietary donor databases, robust screening protocols, and accreditation-focused quality systems tend to command stronger patient trust and referral partnerships. Strategic alliances with genetic testing laboratories, cryopreservation suppliers, and logistic providers enable these organizations to offer end-to-end solutions that reduce friction and variability in outcomes.

Competition is also being shaped by service innovation. Clinics that integrate digital intake, remote counseling, and comprehensive psychosocial support position themselves as full-service providers capable of managing complex care journeys across geographies. At the same time, consolidation among specialized providers and selective partnerships with hospital systems create differentiated referral networks and access to multidisciplinary care for patients with concomitant medical needs. Operational excellence - reflected in transparent pricing, timely patient communication, and demonstrable quality metrics - remains a core differentiator in a market where reputation and outcomes drive patient decision-making.

Emerging players are leveraging targeted specialization and niche service offerings, such as donor matching algorithms, customizable donor anonymity options, and concierge coordination for out-of-region patients. These approaches broaden competitive strategies beyond price, enabling value-based differentiation that resonates with both self-funded patients and those navigating partial or full coverage pathways.

Practical and prioritized recommendations for clinic operators and health system leaders to strengthen clinical resilience, payer collaboration, and patient-centric service delivery

To thrive amid clinical and economic headwinds, industry leaders must take decisive, prioritized actions that reinforce clinical quality and patient trust while enhancing operational agility. First, diversify supply chains and develop domestic maintenance and inventory capabilities for critical equipment and consumables to reduce vulnerability to trade disruptions and tariff-induced delays. Parallel to this, invest in cryopreservation capacity and validated protocols that allow flexible scheduling and broaden the clinic's geographic sourcing footprint.

Second, deepen payer engagement through transparent outcome tracking and value-based contracting pilots where feasible, while also expanding patient financing options and clear pricing communication for self-funded individuals. Third, elevate digital patient journeys by integrating telehealth assessments, remote counseling, and centralized care coordination to compress timelines and improve adherence to treatment protocols. Fourth, strengthen donor governance through enhanced screening, consent management, and long-term data stewardship to address ethical concerns and regulatory scrutiny.

Fifth, pursue targeted partnerships with genetic testing laboratories, logistics providers, and referral networks to offer end-to-end continuity of care for cross-border patients. Finally, implement robust data analytics to monitor clinical performance, patient satisfaction, and operational KPIs, using these insights to iterate on care pathways and resource allocation decisions. Together, these actions will help organizations maintain high standards of care while adapting to shifting payer and policy environments.

Transparent mixed-methods research approach combining stakeholder interviews, clinic surveys, and regulatory synthesis to produce actionable and validated sector insights

The analysis synthesizes findings from a mixed-methods research design combining primary stakeholder engagement and comprehensive secondary review. Primary research included structured interviews with clinical leaders, laboratory directors, procurement specialists, and patient advocacy representatives to surface operational challenges, payer interactions, and patient experience trends. These qualitative insights were complemented by targeted surveys that captured clinic-level practices around donor recruitment, cryopreservation protocols, and telehealth integration.

Secondary research consisted of systematic review of regulatory guidance, professional society recommendations, and published clinical literature to validate best-practice models and ethical frameworks. Data triangulation techniques were applied to reconcile divergent perspectives and ensure that conclusions reflect both operational realities and clinical standards. Segment mapping was used to align insights with source type, donor relationships, payment modalities, recipient age cohorts, and clinic formats, enabling nuanced recommendations tailored to distinct provider archetypes.

Throughout the research process, emphasis was placed on methodological transparency, rigorous source validation, and stakeholder corroboration to ensure the findings are robust and operationally relevant. Confidentiality safeguards were maintained for interview participants, and synthesis prioritized actionable intelligence over speculative conjecture.

Concluding synthesis highlighting strategic priorities, risk areas, and the balanced approach required to sustain clinical excellence and operational agility in IVF services

In conclusion, the donor egg IVF landscape presents a complex mix of opportunity and risk that requires deliberate strategic responses from clinical providers, payers, and policy stakeholders. Technological advancements and improved cryopreservation fidelity are expanding clinical options and enabling more flexible service models, while digital care pathways are improving access and patient experience. At the same time, trade policy dynamics, payer variability, and heightened ethical scrutiny introduce operational and reputational risks that must be actively managed.

Organizations that prioritize supply chain resilience, rigorous donor governance, and transparent patient engagement will be better positioned to capture demand across both domestic and cross-border segments. Those that couple clinical excellence with differentiated service models - including integrated telehealth, strong partnerships, and outcome transparency - can build sustainable competitive advantages. The path forward requires a balanced focus on clinical outcomes, operational efficiency, and stakeholder collaboration to ensure that services remain accessible, safe, and aligned with evolving patient expectations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Donor Egg IVF Services Market, by Source Type

  • 8.1. Fresh Donor Eggs
  • 8.2. Frozen Donor Eggs

9. Donor Egg IVF Services Market, by Donor Type

  • 9.1. Anonymous
  • 9.2. Known
    • 9.2.1. Friend
    • 9.2.2. Sibling

10. Donor Egg IVF Services Market, by Payment Model

  • 10.1. Insurance-Covered
    • 10.1.1. Full Coverage
    • 10.1.2. Partial Coverage
  • 10.2. Self-Funded

11. Donor Egg IVF Services Market, by Recipient Age Group

  • 11.1. 35 To 45
  • 11.2. Over 45
  • 11.3. Under 35

12. Donor Egg IVF Services Market, by Clinic Type

  • 12.1. General Hospitals
  • 12.2. Specialized Fertility Clinics
    • 12.2.1. Chain
    • 12.2.2. Independent

13. Donor Egg IVF Services Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Donor Egg IVF Services Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Donor Egg IVF Services Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Donor Egg IVF Services Market

17. China Donor Egg IVF Services Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Akruti IVF Centre LLP
  • 18.6. Apollo Fertility
  • 18.7. Birla Fertility and IVF Center
  • 18.8. CCRM North America, Inc.
  • 18.9. Cloudnine Fertility
  • 18.10. Cryos International A/S
  • 18.11. Donor Egg Bank USA LLC
  • 18.12. Fairfax Reproductive Services, LLC
  • 18.13. Gaudium IVF Pvt. Ltd.
  • 18.14. Genea Pty Ltd
  • 18.15. Human Potential, Inc.
  • 18.16. Indira IVF Hospital Pvt. Ltd.
  • 18.17. Milann Fertility Centre
  • 18.18. Morpheus Life Sciences Pvt. Ltd.
  • 18.19. Nova IVF Fertility Pvt. Ltd.
  • 18.20. Ovogene Ltd.
  • 18.21. Prelude Fertility, Inc.
  • 18.22. Raffles Medical Group Ltd.
  • 18.23. SGF Fertility Services, LLC
  • 18.24. Sims IVF Fertility Clinic Ltd.
  • 18.25. The Boston IVF Collaborative, LLC
  • 18.26. The Cape Fertility Clinic (Pty) Ltd.
  • 18.27. Virtus Health Ltd.
  • 18.28. Virtus Reproductive Partners, LLC
  • 18.29. World Fertility Services Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DONOR EGG IVF SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DONOR EGG IVF SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA DONOR EGG IVF SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FRESH DONOR EGGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FRESH DONOR EGGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FRESH DONOR EGGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FROZEN DONOR EGGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FROZEN DONOR EGGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FROZEN DONOR EGGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY ANONYMOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY ANONYMOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY ANONYMOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FRIEND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FRIEND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FRIEND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SIBLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SIBLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SIBLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FULL COVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FULL COVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FULL COVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY PARTIAL COVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY PARTIAL COVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY PARTIAL COVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SELF-FUNDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SELF-FUNDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SELF-FUNDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY 35 TO 45, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY 35 TO 45, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY 35 TO 45, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY OVER 45, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY OVER 45, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY OVER 45, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY UNDER 35, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY UNDER 35, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY UNDER 35, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY CHAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY CHAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY CHAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 144. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 148. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 149. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 150. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 171. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 175. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 176. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 177. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 180. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 184. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 185. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 186. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA DONOR EGG IVF SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)